Robert Covert

790 total citations
27 papers, 394 citations indexed

About

Robert Covert is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Endocrine and Autonomic Systems. According to data from OpenAlex, Robert Covert has authored 27 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Pediatrics, Perinatology and Child Health and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Robert Covert's work include Neonatal Respiratory Health Research (10 papers), Neonatal and fetal brain pathology (6 papers) and Prenatal Substance Exposure Effects (6 papers). Robert Covert is often cited by papers focused on Neonatal Respiratory Health Research (10 papers), Neonatal and fetal brain pathology (6 papers) and Prenatal Substance Exposure Effects (6 papers). Robert Covert collaborates with scholars based in United States. Robert Covert's co-authors include Michael D. Schreiber, Ian R. Tebbett, Christine Moore, Anna M. Dusick, Robert Mittendorf, Phyllis A. Gimotty, Kwang‐Sun Lee, Peter G. Pryde, Josef Neu and Willa H. Drummond and has published in prestigious journals such as Journal of Applied Physiology, Journal of Pharmacology and Experimental Therapeutics and American Journal of Preventive Medicine.

In The Last Decade

Robert Covert

27 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Covert United States 12 168 114 89 60 60 27 394
Sharon R Siegel United States 14 485 2.9× 255 2.2× 101 1.1× 82 1.4× 11 0.2× 41 775
John D. Madden United States 8 417 2.5× 36 0.3× 43 0.5× 87 1.4× 20 0.3× 9 554
David C. Winston United States 8 58 0.3× 87 0.8× 21 0.2× 11 0.2× 54 0.9× 20 326
J. Galli United States 8 45 0.3× 268 2.4× 38 0.4× 44 0.7× 36 0.6× 16 565
M. Masson Canada 10 123 0.7× 165 1.4× 88 1.0× 33 0.6× 3 0.1× 20 561
Herbert E. Gilmore United States 8 110 0.7× 33 0.3× 33 0.4× 13 0.2× 9 0.1× 10 244
BJ Smit Netherlands 9 226 1.3× 155 1.4× 25 0.3× 61 1.0× 8 0.1× 9 313
Debabrata Roy United Kingdom 11 36 0.2× 17 0.1× 42 0.5× 46 0.8× 7 0.1× 42 377
Luc Desfrère France 13 110 0.7× 203 1.8× 106 1.2× 54 0.9× 28 509
Bryan V. Acton Canada 9 119 0.7× 83 0.7× 77 0.9× 7 0.1× 4 0.1× 15 262

Countries citing papers authored by Robert Covert

Since Specialization
Citations

This map shows the geographic impact of Robert Covert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Covert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Covert more than expected).

Fields of papers citing papers by Robert Covert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Covert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Covert. The network helps show where Robert Covert may publish in the future.

Co-authorship network of co-authors of Robert Covert

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Covert. A scholar is included among the top collaborators of Robert Covert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Covert. Robert Covert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mittendorf, Robert, Robert Covert, Anthony Montag, et al.. (2005). Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates. Journal of Perinatal Medicine. 33(5). 428–34. 45 indexed citations
2.
Mittendorf, Robert, Robert Covert, Peter G. Pryde, et al.. (2004). Association between Lenticulostriate Vasculopathy (LSV) and Neonatal Intraventricular Hemorrhage (IVH). Journal of Perinatology. 24(11). 700–705. 13 indexed citations
3.
Allen, Katrina J., et al.. (2002). Fetal Gender and Cocaine Exposure as Determinants of Cord Blood Gamma-Glutamyl Transferase Activity. Journal of Perinatology. 22(2). 133–136. 1 indexed citations
4.
Mittendorf, Robert, et al.. (2001). The Association of Coagulase-Negative Staphylococci Isolated from the Chorioamnion at Delivery and Subsequent Development of Cerebral Palsy. Journal of Perinatology. 21(1). 3–8. 14 indexed citations
5.
Mittendorf, Robert, Robert Covert, Ronald J. Elin, et al.. (2001). Umbilical Cord Serum Ionized Magnesium Level and Total Pediatric Mortality. Obstetrics and Gynecology. 98(1). 75–78. 4 indexed citations
6.
Srisuparp, Pimol, Jeremy D. Marks, Stephen Wall, et al.. (1998). Safety of Inhaled Nitric Oxide in the Treatment of Premature Newborn Infants with Respiratory Distress Syndrome † 1146. Pediatric Research. 43. 197–197. 1 indexed citations
7.
Covert, Robert, et al.. (1997). Hydrometrocolpos as a neonatal manifestation of the Bardet-Biedl syndrome. American Journal of Medical Genetics. 69(2). 220–220. 16 indexed citations
8.
Hanlon‐Lundberg, Kathleen M., et al.. (1996). Accelerated Fetal Lung Maturity Profiles and Maternal Cocaine Exposure. Obstetrics and Gynecology. 87(1). 128–132. 10 indexed citations
9.
Herschel, Marguerite, Hui‐Lung Hsieh, Robert Mittendorf, et al.. (1995). Fetal Death in a Population of Black Women. American Journal of Preventive Medicine. 11(3). 185–189. 9 indexed citations
10.
11.
Covert, Robert & Willa H. Drummond. (1994). Hemodynamic Interaction of Chloralose Pretreatment with Subsequent β-Adrenergic Receptor Antagonism in Lambs. Neonatology. 66(6). 316–323. 3 indexed citations
12.
Schreiber, Michael D., et al.. (1994). Effects of cocaine, benzoylecgonine, and cocaine metabolites in cannulated pressurized fetal sheep cerebral arteries. Journal of Applied Physiology. 77(2). 834–839. 39 indexed citations
13.
Dusick, Anna M., et al.. (1993). Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants. The Journal of Pediatrics. 122(3). 438–445. 51 indexed citations
14.
15.
Schreiber, Michael D., et al.. (1992). Hemodynamic Effects of Heat-Killed Group B β-Hemolytic Streptococcus in Newborn Lambs: Role of Leukotriene D4. Pediatric Research. 31(2). 121–126. 13 indexed citations
16.
Tebbett, Ian R., et al.. (1992). Analysis of meconium for cocaine in neonates. Journal of Chromatography B Biomedical Sciences and Applications. 575(1). 158–161. 30 indexed citations
17.
Schreiber, Michael D., et al.. (1992). Effect of aminophylline on the pulmonary and systemic hemodynamic response to group B beta-hemolytic Streptococcus and leukotriene D4 in newborn lambs.. PubMed. 17(4). 195–200. 2 indexed citations
18.
Covert, Robert, Willa H. Drummond, Phyllis A. Gimotty, & Randolph L. Carter. (1989). Chloralose Alters Both Basal Hemodynamics and Cardiovascular Responses to Alveolar Hypoxia in Chronically Instrumented, Spontaneously Breathing Lambs'. Pediatric Research. 25(4). 389–395. 8 indexed citations
19.
Covert, Robert, et al.. (1988). Pulmonary and systemic vascular response to promethazine in conscious lambs. Pediatric Cardiology. 9(3). 137–141. 2 indexed citations
20.
Covert, Robert, Willa H. Drummond, & Phyllis A. Gimotty. (1988). Chloralose alters circulatory response to alpha-receptor stimulation and blockade. American Journal of Physiology-Heart and Circulatory Physiology. 255(3). H419–H425. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon R Siegel Breakdown of academic impact, for papers by John D. Madden Breakdown of academic impact, for papers by David C. Winston Breakdown of academic impact, for papers by J. Galli Breakdown of academic impact, for papers by M. Masson Breakdown of academic impact, for papers by Herbert E. Gilmore Breakdown of academic impact, for papers by BJ Smit Breakdown of academic impact, for papers by Debabrata Roy Breakdown of academic impact, for papers by Luc Desfrère Breakdown of academic impact, for papers by Bryan V. Acton
Rankless by CCL
2026